Status:
COMPLETED
Managing Pain in Patients With MTP Arthritis
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
VKTRY Gear
Conditions:
Hallux Rigidus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hallux rigidus is a degenerative disease of the first metatarsophalangeal (MTP) joint which affect 2.5% of people over the age of 50. As the arthritis progresses, patients pain levels increase and ran...
Detailed Description
Subject Enrollment: Patients were introduced to the study by Foot and Ankle orthopaedic surgeons if they were identified as having hallux rigidis. If the patient agreed, an authorized member of the s...
Eligibility Criteria
Inclusion
- Adult patients (over 18 years old) with MTP joint arthritis
- Adults who were competent and able to consent on their behalf
- Patients who were seen at Massachusetts General Hospital and Newton Wellesley Hospital
Exclusion
- Patients who had history of 1st MTP joint injection
- Patients that have already used similar orthotics or had prior surgery to the foot
- Patients who will be treated surgically
Key Trial Info
Start Date :
April 30 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2020
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT04833608
Start Date
April 30 2019
End Date
May 31 2020
Last Update
April 6 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02120
2
Newton Wellesley Hospital
Newton, Massachusetts, United States, 02462